These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16716113)

  • 21. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice.
    Benchaouir R; Meregalli M; Farini A; D'Antona G; Belicchi M; Goyenvalle A; Battistelli M; Bresolin N; Bottinelli R; Garcia L; Torrente Y
    Cell Stem Cell; 2007 Dec; 1(6):646-57. PubMed ID: 18371406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skipping.
    Bish LT; Sleeper MM; Forbes SC; Wang B; Reynolds C; Singletary GE; Trafny D; Morine KJ; Sanmiguel J; Cecchini S; Virag T; Vulin A; Beley C; Bogan J; Wilson JM; Vandenborne K; Kornegay JN; Walter GA; Kotin RM; Garcia L; Sweeney HL
    Mol Ther; 2012 Mar; 20(3):580-9. PubMed ID: 22146342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells.
    De Angelis FG; Sthandier O; Berarducci B; Toso S; Galluzzi G; Ricci E; Cossu G; Bozzoni I
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9456-61. PubMed ID: 12077324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functionalized PEG-PEI copolymers complexed to exon-skipping oligonucleotides improve dystrophin expression in mdx mice.
    Sirsi SR; Schray RC; Guan X; Lykens NM; Williams JH; Erney ML; Lutz GJ
    Hum Gene Ther; 2008 Aug; 19(8):795-806. PubMed ID: 18647087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gene therapy for muscular dystrophy].
    Takeda S
    No To Hattatsu; 2004 Mar; 36(2):117-23. PubMed ID: 15031985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
    Yin H; Moulton HM; Betts C; Seow Y; Boutilier J; Iverson PL; Wood MJ
    Hum Mol Genet; 2009 Nov; 18(22):4405-14. PubMed ID: 19692354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice.
    Yin H; Lu Q; Wood M
    Mol Ther; 2008 Jan; 16(1):38-45. PubMed ID: 17968354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models.
    Quenneville SP; Chapdelaine P; Skuk D; Paradis M; Goulet M; Rousseau J; Xiao X; Garcia L; Tremblay JP
    Mol Ther; 2007 Feb; 15(2):431-8. PubMed ID: 17235323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides.
    Wilton SD; Lloyd F; Carville K; Fletcher S; Honeyman K; Agrawal S; Kole R
    Neuromuscul Disord; 1999 Jul; 9(5):330-8. PubMed ID: 10407856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. U1 snRNA as an effective vector for stable expression of antisense molecules and for the inhibition of the splicing reaction.
    Martone J; De Angelis FG; Bozzoni I
    Methods Mol Biol; 2012; 867():239-57. PubMed ID: 22454066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A canine minidystrophin is functional and therapeutic in mdx mice.
    Wang B; Li J; Qiao C; Chen C; Hu P; Zhu X; Zhou L; Bogan J; Kornegay J; Xiao X
    Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dystrophin rescue by trans-splicing: a strategy for DMD genotypes not eligible for exon skipping approaches.
    Lorain S; Peccate C; Le Hir M; Griffith G; Philippi S; Précigout G; Mamchaoui K; Jollet A; Voit T; Garcia L
    Nucleic Acids Res; 2013 Sep; 41(17):8391-402. PubMed ID: 23861443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle regeneration affects Adeno Associated Virus 1 mediated transgene transcription.
    Mollard A; Peccate C; Forand A; Chassagne J; Julien L; Meunier P; Guesmia Z; Marais T; Bitoun M; Piétri-Rouxel F; Benkhelifa-Ziyyat S; Lorain S
    Sci Rep; 2022 Jun; 12(1):9674. PubMed ID: 35690627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A
    Echigoya Y; Trieu N; Duddy W; Moulton HM; Yin H; Partridge TA; Hoffman EP; Kornegay JN; Rohret FA; Rogers CS; Yokota T
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineering multiple U7snRNA constructs to induce single and multiexon-skipping for Duchenne muscular dystrophy.
    Goyenvalle A; Wright J; Babbs A; Wilkins V; Garcia L; Davies KE
    Mol Ther; 2012 Jun; 20(6):1212-21. PubMed ID: 22354379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice.
    Bostick B; Yue Y; Lai Y; Long C; Li D; Duan D
    Hum Gene Ther; 2008 Aug; 19(8):851-6. PubMed ID: 18666839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy.
    Wang Q; Yin H; Camelliti P; Betts C; Moulton H; Lee H; Saleh AF; Gait MJ; Wood MJ
    J Gene Med; 2010 Apr; 12(4):354-64. PubMed ID: 20235089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.
    Hanson B; Wood MJA; Roberts TC
    RNA Biol; 2021 Jul; 18(7):1048-1062. PubMed ID: 33472516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosing regimen has a significant impact on the efficiency of morpholino oligomer-induced exon skipping in mdx mice.
    Malerba A; Thorogood FC; Dickson G; Graham IR
    Hum Gene Ther; 2009 Sep; 20(9):955-65. PubMed ID: 19469709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy?
    Wilton SD; Dye DE; Blechynden LM; Laing NG
    Neuromuscul Disord; 1997 Jul; 7(5):329-35. PubMed ID: 9267847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.